The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base
- PMID: 18553367
- DOI: 10.1002/cncr.23572
The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base
Abstract
Background: Regional-based studies have indicated that ethnicity is associated with presentation and outcome in patients with gastric adenocarcinoma. To validate this observation in a large cohort, the authors of this report used the National Cancer Data Base (NCDB) to determine whether self-reported ethnicity influences presentation and survival in this patient population.
Methods: Patient demographics, tumor-related features, and treatment-related features were analyzed by ethnicity. Univariate analyses were performed using the chi-square test. Overall median and relative survival rates were examined by using the Kaplan-Meier method. Cox proportional-hazards models were used to identify the predictors of survival outcomes.
Results: Between 1995 and 2002, 81,095 cases of gastric adenocarcinoma were entered into the NCDB. There were 57,943 white patients (71.5%), 11,094 African-American patients (13.7%), 5665 Hispanic patients (7%), 4736 Asian/Pacific Islander (API) patients (5.8%), and 1657 patients of other ethnicities (2%). Significant differences were observed according to ethnicity among the variables that were compared (all P < .01). In patients with stage I and II disease, the 5-year relative survival rates for APIs (stage I, 77.2%; stage II, 48%) were more favorable than for whites (stage I, 58.7%; stage II, 32.8%), African Americans (stage I, 55.9%; stage II, 37.9%), and Hispanics (stage I, 60.8%; stage II, 39.3%). The overall median survival of APIs was more favorable than that of others (P < .01). Predictors of a better outcome were Asian race, female sex, younger age, earlier stage, lower grade, distal tumors, multimodality treatment, and care at a teaching hospital.
Conclusions: Ethnicity was associated with differences in presentation and outcome of patients with gastric adenocarcinoma. APIs had a more favorable outcome than patients of other ethnicities. Further studies should target underlying biologic and socioeconomic factors to explain these differences.
(c) 2008 American Cancer Society
Similar articles
-
Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a canadian cancer center.J Clin Oncol. 2003 Jun 1;21(11):2070-6. doi: 10.1200/JCO.2003.11.054. J Clin Oncol. 2003. PMID: 12775731
-
Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?J Surg Oncol. 2007 Feb 1;95(2):118-22. doi: 10.1002/jso.20328. J Surg Oncol. 2007. PMID: 17262741
-
Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.Cancer. 2006 Nov 1;107(9):2143-51. doi: 10.1002/cncr.22229. Cancer. 2006. PMID: 17001662
-
Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.Ear Nose Throat J. 2008 Nov;87(11):634-43. Ear Nose Throat J. 2008. PMID: 19006065 Review.
-
Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract.Cancer. 2005 Jun 1;103(11):2355-62. doi: 10.1002/cncr.21082. Cancer. 2005. PMID: 15856426 Review.
Cited by
-
New metastatic lymph node classification for early gastric cancer should differ from those for advanced gastric adenocarcinoma: Results based on the SEER database.World J Clin Cases. 2019 Jan 26;7(2):145-155. doi: 10.12998/wjcc.v7.i2.145. World J Clin Cases. 2019. PMID: 30705892 Free PMC article.
-
Comparison the sixth and seventh editions of the AJCC staging system for T1 gastric cancer: a long-term follow-up study of 2124 patients.Gastric Cancer. 2017 Jan;20(1):43-48. doi: 10.1007/s10120-015-0590-0. Epub 2016 Jan 5. Gastric Cancer. 2017. PMID: 26732877
-
Anti-angiogenic Therapy in Patients with Advanced Gastric and Gastroesophageal Junction Cancer: A Systematic Review.Cancer Res Treat. 2017 Oct;49(4):851-868. doi: 10.4143/crt.2016.176. Epub 2017 Jan 3. Cancer Res Treat. 2017. PMID: 28052652 Free PMC article.
-
Clinicopathological Characteristics and Survival Predictions for Adenocarcinoma of the Esophagogastric Junction: A SEER Population-Based Retrospective Study.Int J Gen Med. 2021 Dec 24;14:10303-10314. doi: 10.2147/IJGM.S341405. eCollection 2021. Int J Gen Med. 2021. PMID: 34992445 Free PMC article.
-
Descriptive epidemiology of gastric adenocarcinoma in the state of Texas by ethnicity: Hispanic versus White non-Hispanic.Gastric Cancer. 2012 Oct;15(4):405-13. doi: 10.1007/s10120-011-0127-0. Epub 2012 Jan 18. Gastric Cancer. 2012. PMID: 22252153
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical